Dog Immune-Mediated Polyarthritis Welfare

Immune-mediated polyarthritis (IMPA) causes painful joint inflammation in dogs and requires accurate diagnosis and sustained immunosuppressive treatment to restore quality of life.

Key Facts

IMPA is the most common immune-mediated joint disease in dogs, affecting multiple joints simultaneously
The condition is classified as primary (idiopathic) or secondary (associated with infection, drugs, or other diseases)
Clinical signs include shifting leg lameness, joint swelling, fever, and reluctance to move or be touched
Diagnosis requires joint fluid analysis showing non-infectious inflammatory cells in multiple joints
Treatment with corticosteroids achieves remission in most cases, but relapses require long-term management

Welfare Considerations

IMPA can be profoundly debilitating before diagnosis - a dog cycling through multiple joints that alternately swell and apparently resolve may go weeks or months before the pattern is recognized. Pain during the active inflammatory phase is severe, affecting mobility, sleep, appetite, and social interaction. Once diagnosed and treated, the welfare trajectory improves dramatically, but owner compliance with treatment and monitoring schedules is critical for sustained remission.

What You Can Do

If your dog develops shifting lameness with fever and joint swelling, pursue specialist evaluation promptly
Work with an internist for diagnosis - joint taps from multiple joints are essential for accurate classification
Maintain immunosuppressive treatment as directed even when the dog appears normal
Monitor for treatment side effects and discuss dose reduction protocols with your vet
Schedule regular rechecks to catch relapses before they become severe